Too much success? A booming biotech pipeline will spur intense rivalries — analyst

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 11, 2018 at 10:32 AM.

  1. #1 cafead, Dec 11, 2018 at 10:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,024
    Likes Received:
    3
    via Over the last 5 years biotech has been booming. And that could pose a big problem for everyone involved. Like others in the industry, Leerink’s Geoffrey Porges hasn’t overlooked evidence that every hot new target in drug discovery quickly attracts a cluster of biopharma companies.

    article source
     
    Quote

Reply to Thread